Library | SDGs
GOAL 03: Good Health and Well-being
Refine
54 results
REFINE
SHOW: 16
A practical guide for business: Air pollutant emission assessment
This guide provides businesses with a framework to quantify air pollutant emissions along their value chains. It offers methodologies for assessing emissions from key sources such as electricity, fuel combustion, and transportation, helping businesses reduce pollutants and support better health outcomes and environmental sustainability.
Food Systems Dashboard
The Food Systems Dashboard is a comprehensive tool providing insights into global food systems. It offers data on food production, consumption, and nutrition, enabling users to analyse and compare food systems across countries. This tool supports informed decision-making for improving food security and sustainability.
Global Alliance for Improved Nutrition (GAIN)
Global Alliance for Improved Nutrition (GAIN) is an international organisation focused on tackling malnutrition and improving nutrition worldwide. GAIN works with partners to create sustainable, scalable solutions, improving access to nutritious food. Their initiatives target vulnerable populations, aiming to enhance health and well-being through better nutrition.
Work Health Index
The Work Health Index tool measures workplace health and wellbeing across various sectors. It provides organisations with insights into their performance, highlighting areas for improvement and enabling data-driven strategies to enhance employee wellbeing and productivity.
Beyond an age of waste: Turning rubbish into a resource
The report highlights the urgent need to rethink waste as a resource. It emphasises the significance of reducing waste generation, improving waste management practices, and transitioning towards a circular economy to mitigate the environmental impacts of waste. The report presents scenarios for future waste management and advocates for global action to prevent a worsening waste crisis.
UNEP FI Human Rights Guidance Tool
The UNEP FI Human Rights Toolkit provides finance professionals with comprehensive guidance on integrating human rights considerations into governance, policies, and practices. It includes step-by-step instructions for implementing international standards, driving organisational change, and engaging with companies to promote human rights.
The global slavery index 2023
This report reveals that 50 million people live in modern slavery. It highlights the G20's $468 billion worth of high-risk imports and identifies North Korea, Eritrea, and Mauritania as having the highest prevalence. Australia, the Netherlands, and the UK have the strongest government responses.
UN Environment Programme's emissions gap report series
This benchmark report, produced by the United Nations Environment Programme, assesses the discrepancy between projected and necessary global greenhouse gas emissions to meet the Paris Agreement targets. It highlights the urgent need for enhanced mitigation actions and tracks progress on national commitments and policy implementations.
Measuring what matters: Australia's first well-being framework
Measuring What Matters is Australia's first wellbeing framework, published in July 2023 by the Commonwealth of Australia. It seeks to deepen our understanding of how Australians are faring beyond traditional economic indicators. The framework includes 50 wellbeing indicators under the themes of healthy, secure, sustainable, cohesive, and prosperous societies.
Investor toolkit on human rights
This toolkit provides practical guidance for institutional investors to assess and address human rights risks within investment activities. With tools, case studies and standard-setting activities, this investor toolkit encourages proactive management of human rights risks.
Corporate resilience and response to COVID-19
This paper explores COVID-19's impact on corporate resilience and the effectiveness of corporate responses. Analysis of 2,000 companies shows that firms that invested in stakeholder relations performed better. The study reveals machine learning-linked big data provides new means to measure corporate responses and crisis management.
Assessing pharma companies’ response to COVID-19 and the threat of future pandemics
This report analyses pharmaceutical companies’ response during the initial stage of the COVID-19 pandemic, their performance in terms of registration and applying equitable access strategies for COVID-19 vaccines, voluntary licensing agreements and technology transfers, and forward-looking assessment of their preparedness for future epidemics and pandemics.
Innovation and resilience: A global snapshot of social enterprise responses to Covid-19
This report offers a global overview of social enterprise responses to the Covid-19 pandemic. It identifies innovation and agility as critical factors for survival. However, it notes that women-led and youth-led social enterprises face higher closure rates, greater reductions in activity, and more limited access to government support.
Tobacco free portfolios: The toolkit 12th edition
This toolkit offers a framework for finance professionals to invest in tobacco-free portfolios. The toolkit covers various areas including the Tobacco-Free Finance Pledge, prospective investment risks and case studies, with a call to action for the industry to follow.
Political leadership on climate change: The role of health in Obama-era U.S. climate policies
The role of health in Obama-era U.S. climate policies was analysed using a qualitative research approach. Findings show that the consideration of human health-related evidence and arguments facilitated the introduction of comparatively ambitious mitigation policies. This report suggests the importance of political will in the pursuit of climate mitigation policies.
Are pharma companies addressing sexual and reproductive health access barriers for women and girls?
This report examines the role of pharmaceutical companies in addressing access barriers hindering women and girls’ sexual and reproductive health and rights (SRHR) globally. It assesses their research on new SRHR medicines and products, pricing strategies, company capacity building efforts, and inclusive business models.